Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCleantech Lithium Regulatory News (CTL)

Share Price Information for Cleantech Lithium (CTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.263%)
Open: 19.50
High: 19.50
Low: 19.50
Prev. Close: 19.50
CTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PrimaryBid Offer

20 Oct 2022 17:09

RNS Number : 6233D
CleanTech Lithium PLC
20 October 2022
 

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF CLEANTECH LITHIUM PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021).

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA OR JAPAN.

 

 

20 October 2022

 

CleanTech Lithium PLC

("CleanTech" or the "Company")

PrimaryBid Offer

· CleanTech Lithium PLC announces a retail offer via PrimaryBid;

· The Issue Price for the New Ordinary Shares is 47 p per New Ordinary Share, representing a discount of approximately 3.98 per cent to the 10 day VWAP per Ordinary Share on 19 October 2022;

· Investors can access the PrimaryBid Offer by visiting www.primarybid.com and downloading the PrimaryBid mobile app;

· Investors may also be able to take part through PrimaryBid's extensive network of retail brokers, wealth managers and investment platforms. Subscriptions through these partners can be made from tax efficient savings vehicles such as ISAs or SIPPs, as well as General Investment Accounts (GIAs);

· Both the Placing Shares and New Ordinary Shares will be sold at the Issue Price;

· There is a minimum subscription of £250 per investor in the PrimaryBid Offer;

· No commission is charged by PrimaryBid on applications to the PrimaryBid Offer.

PrimaryBid Offer

CleanTech Lithium PLC ("CleanTech", the "Group" or the "Company"), a quoted company involved in the exploration and development of three lithium projects in Chile, is pleased to announce a conditional offer for subscription via PrimaryBid (the "PrimaryBid Offer") of up to 1,063,830 new Ordinary Shares of 1 pence each in the Company ("New Ordinary Shares") at an issue price of 47 pence per New Ordinary Share (the "Issue Price"), being a discount of approximately 3.98 per cent to the 10 day VWAP per Ordinary Share on 19 October 2022. The Company is also conducting a placing of new Ordinary Shares (the "Placing Shares") at the Issue Price by way of an accelerated bookbuild process (the "Placing", together with the PrimaryBid Offer, the "Fundraising") as announced earlier today.

The Fundraising will be subject to shareholder approval to allot the Placing Shares and the New Ordinary Shares at the General Meeting, expected to take place on or around 14 November 2022.

 

The Fundraising is also conditional on the new Ordinary Shares to be issued pursuant to the PrimaryBid Offer and the Placing being admitted to trading on AIM ("Admission"). Admission is expected to be take place at 8.00 a.m. on 16 November 2022. The PrimaryBid Offer will not be completed without the Placing also being completed.

 

The Company will use the net proceeds from the Fundraising to enhance the development of the Company's three strategic assets in Chile through (1) new resource evaluation programmes to seek additional resource, (2) maintaining momentum towards early production of battery grade lithium for the international markets through environmental, scoping, hydrogeological and feasibility studies, and (3) to finance the Group's working capital requirements whilst it remains in a pre-revenue stage of development.

 

Reason for the PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying through the PrimaryBid mobile app available on the Apple App Store and Google Play. Investors may also apply to participate in the PrimaryBid Offer through their ISAs, SIPP or GIA by contacting their retail broker, wealth manager or investment platform. PrimaryBid does not charge investors any commission for these services.

Brokers wishing to offer their customers access to the PrimaryBid Offer, and future PrimaryBid transactions, should contact partners@primarybid.com.

The PrimaryBid Offer, via the PrimaryBid mobile app, will be open to individual and institutional investors following the release of this announcement. The PrimaryBid Offer is expected to close around the same time as the Placing. The PrimaryBid Offer may close early if it is oversubscribed.

The Company reserves the right to scale back any order at its discretion. The Company and PrimaryBid reserve the right to reject any application for subscription under the PrimaryBid Offer without giving any reason for such rejection.

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid or the procedure for applications under the PrimaryBid Offer, visit www.PrimaryBid.com or email PrimaryBid at enquiries@primarybid.com. 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing 79,033,242  Ordinary Shares.

CleanTech Lithium PLC

Aldo Boitano/Gordon Stein

Registration number: 139640

Registered office: 7 Castle Street, St Helier, JE2 3BT, Jersey

 

 

 Jersey office: +44 1534 668 321

 

PrimaryBid Limited

Fahim Chowdhury/James Deal

 

enquiries@primarybid.com

Beaumont Cornish Limited, Nominated Advisor

Roland Cornish

 

+44 20 7628 3396

 

 

Celicourt Communications

Felicity Winkles/Philip Dennis

 

 

 

+44 20 8434 2754 cleantech@celicourt.uk

Details of the PrimaryBid Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate through the PrimaryBid Offer. The Company is therefore making the PrimaryBid Offer available exclusively through the PrimaryBid mobile app.

The PrimaryBid Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority. The PrimaryBid Offer is not being made into any jurisdiction where it would be unlawful to do so.

There is a minimum subscription of £250 per investor under the terms of the PrimaryBid Offer which is open to existing shareholders and other investors subscribing via the PrimaryBid mobile app.

For further details please refer to the PrimaryBid website at www.PrimaryBid.com. The terms and conditions on which the PrimaryBid Offer is made, including the procedure for application and payment for New Ordinary Shares, and details regarding how any funds committed will be returned if the Retail Offer does not proceed, is available to all persons who register with PrimaryBid.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on www.PrimaryBid.com and the PrimaryBid mobile app before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

IMPORTANT NOTICES

 

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as nominated adviser to the Company in relation to the Placing and is not acting for any other persons in relation to the Placing. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.

 

This Announcement contains 'forward-looking statements' concerning the Company that are subject to risks and uncertainties. Generally, the words 'will', 'may', 'should', 'continue', 'believes', 'targets', 'plans', 'expects', 'aims', 'intends', 'anticipates' or similar expressions or negatives thereof identify forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond the Company's ability to control or estimate precisely. The Company cannot give any assurance that such forward-looking statements will prove to have been correct. The reader is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Announcement. The Company does not undertake any obligation to update or revise publicly any of the forward-looking statements set out herein, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

Any indication in this Announcement of the price at which ordinary shares have been bought or sold in the past cannot be relied upon as a guide to future performance. No statement in this Announcement is intended as a profit forecast or estimate for any period and no statement in this Announcement should be interpreted to mean that earnings, earnings per share or income, cash flow from operations or free cash flow for the Company, as appropriate, for the current or future years would necessarily match or exceed the historical published earnings, earnings per share or income, cash flow from operations or free cash flow for the Company.

 

No action has been taken by the Company, PrimaryBid or any of their respective affiliates, or any person acting on its or their behalf that would permit an offer of the New Ordinary Shares or possession or distribution of this Announcement or any other offering or publicity material relating to such New Ordinary Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company to inform themselves about, and to observe, such restrictions.

 

No prospectus will be made available in connection with the matters contained in this Announcement and no such prospectus is required (in accordance with the Prospectus Regulation) to be published. Persons needing advice should consult a qualified independent legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

 

This Announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This Announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

 

This Announcement and the information contained herein, is restricted and is not for publication, release or distribution, directly or indirectly, in whole or in part, in or into Australia, Canada, the Republic of South Africa, Japan, Jersey or any other jurisdiction in which such publication, release or distribution would be unlawful. Further, this Announcement is for information purposes only and is not an offer of securities in any jurisdiction. This Announcement has not been approved by the London Stock Exchange, nor is it intended that it will be so approved.

 

Persons distributing this Announcement must satisfy themselves that it is lawful to do so. This Announcement is for information purposes only and shall not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, Canada, Australia, the Republic of South Africa, Japan, Jersey or any other jurisdiction in which the same would be unlawful. Any failure to comply with this restriction may constitute a violation of the securities laws of such jurisdictions. No public offering of the New Ordinary Shares is being made in any such jurisdiction.

 

 

The relevant clearances have not been, nor will they be, obtained from the securities commission of any province or territory of Canada, no prospectus has been lodged with, or registered by, the Australian Securities and Investments Commission or the Japanese Ministry of Finance; the relevant clearances have not been, and will not be, obtained for the South Africa Reserve Bank or any other applicable body in the Republic of South Africa in relation to the New Ordinary Shares and the New Ordinary Shares have not been, nor will they be, registered under or offering in compliance with the securities laws of any state, province or territory of Australia, Canada, the Republic of South Africa, Japan or Jersey. Accordingly, the New Ordinary Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into Australia, Canada, the Republic of South Africa, Japan, Jersey or any other jurisdiction in which such activities would be unlawful.

 

A copy of this document has been delivered to the registrar of companies in accordance with Article 5 of the Companies (General Provisions) (Jersey) Order 2002, and he has given, and has not withdrawn, his consent to its circulation. The Jersey Financial Services Commission has given, and has not withdrawn, its consent under Article 2 of the Control of Borrowing (Jersey) Order 1958 to the issue of securities in the Company. It must be distinctly understood that, in giving these consents, neither the registrar of companies nor the Jersey Financial Services Commission takes any responsibility for the financial soundness of the Company or for the correctness of any statements made, or opinions expressed, with regard to it. The directors of the Company have taken all reasonable care to ensure that the facts stated in this document are true and accurate in all material respects, and that there are no other facts the omission of which would make misleading any statement in the document, whether of facts or of opinion. All the directors accept responsibility accordingly. It should be remembered that the price of securities and the income from them can go down as well as up.

 

 

Information regarding the Company's stated capital, dividend policy, principal establishments, and material contracts, together with details of directors' existing interests and material debentures and loans to which the Company is party can be found in its most recent annual report and accounts, available at https://ctlithium.com/investors/reports-and-presentations/. A copy of the Company's most recent interim financial report is also available via the same address. No amounts are being written off or provided for as goodwill in connection with the Fundraising.

 

Details of the Company's board of directors and principal advisors can be found on the Company's website at https://ctlithium.com/board-management/.

 

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this Announcement. The New Ordinary Shares to be issued or sold pursuant to the Retail Offer will not be admitted to trading or any stock exchange other than the London Stock Exchange.

 

If you are in any doubt about the contents of this document you should consult your stockbroker, bank manager, solicitor, accountant or other financial adviser.

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIRIDLIFIF
Date   Source Headline
31st Mar 202312:54 pmRNSGrant of Options, Exercise of Options and TVR
31st Mar 20239:05 amRNSSecond Price Monitoring Extn
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20237:00 amRNSOperations and Corporate Update
28th Mar 20237:00 amRNSBoard changes to advance next phase of development
24th Feb 20237:00 amRNSProposed Listing on Australian Securities Exchange
22nd Feb 202311:09 amRNSHolding(s) in Company
15th Feb 20237:00 amRNSCommencement of Trading on OTCQB Venture Market
10th Feb 20232:05 pmRNSSecond Price Monitoring Extn
10th Feb 20232:00 pmRNSPrice Monitoring Extension
8th Feb 20239:05 amRNSSecond Price Monitoring Extn
8th Feb 20239:00 amRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSLlamara - Licences Granted and Operational Plans
20th Jan 202310:16 amRNSPreliminary Events Schedule for H1 2023
6th Jan 20237:00 amRNSInvestor Webinar
5th Jan 20237:00 amRNSScoping Study - Laguna Verde Lithium Project
21st Dec 20227:00 amRNSNotice of Scoping Study and Corporate Film
15th Dec 20227:00 amRNSApplication to cross trade on the U.S. OTCQX
6th Dec 20227:00 amRNSOperations and Corporate Update
1st Dec 20222:08 pmRNSTotal Voting Rights
21st Nov 20224:04 pmRNSHolding(s) in Company
14th Nov 20221:14 pmRNSResult of General Meeting and Total Voting Rights
10th Nov 20227:00 amRNSOptions Award, Issue of Equity & TVR
7th Nov 20227:00 amRNSIR Programme: Germany, Switzerland, Australia
24th Oct 20226:00 pmRNSInvestor Webinar and New Corporate Website
24th Oct 20225:25 pmRNSNotice of General Meeting
21st Oct 20227:00 amRNSResults of Fundraising
20th Oct 20225:09 pmRNSPrimaryBid Offer
20th Oct 20224:40 pmRNSProposed Placing
17th Oct 20227:00 amRNSOperations an Corporate Upate
17th Oct 20227:00 amRNSOperations and Corporate Update
14th Oct 20224:42 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSDirect Lithium Extraction Process Work Commences
12th Oct 202211:05 amRNSSecond Price Monitoring Extn
12th Oct 202211:00 amRNSPrice Monitoring Extension
6th Oct 20221:30 pmRNSInvestor Webinar: Francisco Resource & Co. Update
6th Oct 202211:05 amRNSSecond Price Monitoring Extn
6th Oct 202211:00 amRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSFrancisco Basin: Maiden Resource, New Li Discovery
26th Sep 202211:05 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
16th Sep 20223:47 pmRNSGrant of Options & Director/PDMR Shareholdings
15th Sep 20227:00 amRNSInterim Results
13th Sep 202210:49 amRNSResource Upgrade
12th Sep 20227:00 amRNSHolding(s) in Company
9th Sep 20222:06 pmRNSSecond Price Monitoring Extn
9th Sep 20222:01 pmRNSPrice Monitoring Extension
9th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20224:41 pmRNSSecond Price Monitoring Extn
5th Sep 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.